A detailed history of Patton Albertson Miller Group, LLC transactions in Novartis Ag stock. As of the latest transaction made, Patton Albertson Miller Group, LLC holds 5,459 shares of NVS stock, worth $529,959. This represents 0.09% of its overall portfolio holdings.

Number of Shares
5,459
Previous 5,466 0.13%
Holding current value
$529,959
Previous $581,000 7.92%
% of portfolio
0.09%
Previous 0.08%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$106.13 - $120.89 $742 - $846
-7 Reduced 0.13%
5,459 $627,000
Q2 2024

Aug 02, 2024

SELL
$92.57 - $107.37 $19,902 - $23,084
-215 Reduced 3.78%
5,466 $581,000
Q1 2024

Apr 24, 2024

SELL
$95.27 - $108.47 $7,907 - $9,003
-83 Reduced 1.44%
5,681 $549,000
Q4 2023

Feb 07, 2024

SELL
$92.27 - $101.54 $9,227 - $10,154
-100 Reduced 1.71%
5,764 $581,000
Q3 2023

Oct 24, 2023

SELL
$94.73 - $105.13 $4,736 - $5,256
-50 Reduced 0.85%
5,864 $597,000
Q2 2023

Jul 13, 2023

SELL
$92.52 - $104.91 $44,409 - $50,356
-480 Reduced 7.51%
5,914 $596,000
Q1 2023

Apr 21, 2023

SELL
$80.03 - $92.81 $3,201 - $3,712
-40 Reduced 0.62%
6,394 $588,000
Q4 2022

Jan 23, 2023

SELL
$75.55 - $92.52 $36,641 - $44,872
-485 Reduced 7.01%
6,434 $0
Q3 2022

Oct 13, 2022

SELL
$74.61 - $87.26 $46,929 - $54,886
-629 Reduced 8.33%
6,919 $526,000
Q2 2022

Jul 22, 2022

SELL
$80.52 - $93.75 $185,598 - $216,093
-2,305 Reduced 23.39%
7,548 $638,000
Q1 2022

May 02, 2022

BUY
$80.11 - $90.62 $1,041 - $1,178
13 Added 0.13%
9,853 $865,000
Q4 2021

Feb 11, 2022

SELL
$79.7 - $88.13 $209,212 - $231,341
-2,625 Reduced 21.06%
9,840 $861,000
Q3 2021

Oct 27, 2021

SELL
$81.78 - $95.14 $22,489 - $26,163
-275 Reduced 2.16%
12,465 $1.02 Million
Q2 2021

Jul 29, 2021

SELL
$85.24 - $94.15 $90,524 - $99,987
-1,062 Reduced 7.69%
12,740 $1.16 Million
Q1 2021

Apr 21, 2021

BUY
$83.5 - $98.47 $2,087 - $2,461
25 Added 0.18%
13,802 $1.18 Million
Q4 2020

Feb 25, 2021

SELL
$78.07 - $94.43 $93,059 - $112,560
-1,192 Reduced 7.96%
13,777 $1.26 Million
Q3 2020

Nov 03, 2020

SELL
$82.14 - $91.0 $111,546 - $123,578
-1,358 Reduced 8.32%
14,969 $1.3 Million
Q1 2020

May 22, 2020

SELL
$70.67 - $99.01 $26,501 - $37,128
-375 Reduced 2.25%
16,327 $1.35 Million
Q4 2019

Feb 06, 2020

SELL
$84.35 - $95.37 $12,652 - $14,305
-150 Reduced 0.89%
16,702 $1.58 Million
Q3 2019

Nov 13, 2019

SELL
$85.54 - $94.26 $49,442 - $54,482
-578 Reduced 3.32%
16,852 $1.46 Million
Q2 2019

Aug 12, 2019

BUY
$75.4 - $92.8 $1.12 Million - $1.38 Million
14,920 Added 594.42%
17,430 $1.58 Million
Q3 2018

Oct 25, 2018

BUY
$66.94 - $77.43 $168,019 - $194,349
2,510 New
2,510 $211,000
Q1 2018

May 01, 2018

SELL
$70.39 - $84.15 $350,542 - $419,067
-4,980 Closed
0 $0
Q4 2017

Feb 02, 2018

SELL
$72.33 - $77.64 $10,415 - $11,180
-144 Reduced 2.81%
4,980 $418,000
Q3 2017

Oct 06, 2017

BUY
$74.14 - $77.27 $379,893 - $395,931
5,124
5,124 $439,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $209B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Patton Albertson Miller Group, LLC Portfolio

Follow Patton Albertson Miller Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patton Albertson Miller Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patton Albertson Miller Group, LLC with notifications on news.